Addex Therapeutics Q4 EPS $(1.50) Down From $(1.37) YoY, Sales $20.020K Up From $1.719K YoY

Benzinga Newsdesk www.benzinga.com Negative 95.9%

Neg 95.9% Neu 0% Pos 0%

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.50) per share. This is a 9.49 percent decrease over losses of $(1.37) per share from the same period last year. The company reported $20.020 thousand in sales this quarter. This is a 1.06K percent increase over sales of $1.719 thousand the same period last year.